A study compares budesonide-glycopyrrolate-formoterol and fluticasone-umeclidinium-vilanterol, revealing insights on COPD ...

New Study Shows Promising Results for COPD Treatment Nov. 20 ... have found that dual bronchodilators -- long-lasting inhalers that relax the airways and make it easier to breathe -- do little ...

For patients with chronic obstructive pulmonary disease (COPD), budesonide-glycopyrrolate-formoterol does not improve ...

Metered-dose inhaler budesonide-glycopyrrolate-formoterol (Breztri Aerosphere) was associated with a higher risk of a first ...

Manufacturers continually invest in research and development to innovate new respiratory devices and technologies ... The report segments the global COPD and asthma devices market by product type ...

The current pathophysiology of COPD encompasses ... The advantage of this new model is that we now have the opportunity to intervene, and certain investigational medications are now being studied ...

A RECENT study examining real-world COPD treatment outcomes has highlighted safety concerns regarding single-inhaler triple therapy compared to the long-acting beta2-agonist (LABA) and inhaled ...

These are some of the common challenges for people with advanced COPD/emphysema ... endobronchial valves (EBV) offer a new treatment option. The devices are about the size of a pencil eraser ...

“These therapies provide the first new classes of medications approved for COPD in nearly 20 years,” said David M. Mannino, MD, of the University of Kentucky, Lexington, Kentucky, in an interview.

data from the MATINEE study to support the regulatory review process to obtain a new indication for the use of Nucala (mepolizumab) in chronic obstructive pulmonary disease or COPD. The submission ...

Alison says she felt "drastically different" after having the injection and still uses her inhalers ... this is the first new treatment for those suffering from asthma and COPD attacks in 50 ...

is to work with Qualcomm to 'digitally upgrade' its Respimat inhaler, introducing a new connectivity solution to improve medication adherence in chronic obstructive pulmonary disorder (COPD ...